Cellular determinants of reduced adaptability of the aging brain: neurotransmitter utilization and cell signaling responses after MDMA lesions

Brain Research

Volumn 879, Issue 1-2, 2000, Pages 163-173

  Slotkin, T A ^a   Seidler, F J ^a   Ali, S F ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b National Centre   (United States)

Author keywords

Adenylyl cyclase; Aging brain; Dopamine; Methylenedioxymethamphetamine (MDMA); Serotonin (5 HT)

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; ADENYLATE CYCLASE; DOPAMINE; GUANINE NUCLEOTIDE BINDING PROTEIN; MONOAMINE; SEROTONIN;

AGING; ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; BRAIN FUNCTION; BRAIN INJURY; BRAIN REGION; CONTROLLED STUDY; ENZYME ACTIVITY; MOUSE; NERVE DEGENERATION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; REGENERATION; SYNAPSE;

3,4-DIHYDROXYPHENYLACETIC ACID; ADENYLATE CYCLASE; ANIMALS; BIOGENIC MONOAMINES; BRAIN; BRAIN STEM; CAUDATE NUCLEUS; CEREBELLUM; CEREBRAL CORTEX; DOPAMINE; HIPPOCAMPUS; HOMOVANILLIC ACID; HYDROXYINDOLEACETIC ACID; MALE; MICE; MICE, INBRED C57BL; N-METHYLASPARTATE; NEURONS; NEUROTOXINS; PROSENCEPHALON; SEROTONIN; SIGNAL TRANSDUCTION;

EID: 0034613402     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02767-0     Document Type: Article

References (42)

1. Ali S.F., Newport G.D., Holson R.R., Slikker W., Bowyer J.F. Low environmental temperatures or pharmacological agents which produce hypothermia decreases methamphetamine neurotoxicity in mice. Brain Res. 658:1994;33-38.
2. Aune T.M., Kelley K.A., Ranges G.E., Bombara M.P. Serotonin-activated signal transduction via serotonin receptors on Jurkat cells. J. Immunol. 145:1990;1826-1831.
3. Brodde O.E., Zerkowski H.R., Schranz D., Broedesitz A., Michel-Reher M., Schafer-Beisenbusch E., Piotrowski J.A., Oelert H. Age-dependent changes in the β-adrenoceptor-G-protein(s)-adenylyl cyclase system in human right atrium. J. Cardiovasc. Pharmacol. 26:1995;20-26.
4. Broening H.W., Bowyer J.F., Slikker W. Age-dependent sensitivity of rats to the long-term effects of the serotonergic neurotoxicant 3,4-methylenedioxymethamphetamine (MDMA) correlates with the magnitude of the MDMA-induced thermal response. J. Pharmacol. Exp. Ther. 275:1995;325-333.
5. 2-noradrenergic system: effects on cognition. Drugs Aging. 5:1994;116-126.
6. Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. J. Affect. Disord. 18:1990;289-299.
7. Fumagalli F., Jones S.R., Caron M.G., Seidler F.J., Slotkin T.A. Expression of mRNA coding for the serotonin transporter in aged vs. young rat brain: differential effects of glucocorticoids. Brain Res. 719:1996;225-228.
8. Gao M.H., Ping P.P., Post S., Insel P.A., Tang R.Y., Hammond H.K. Increased expression of adenylylcyclase type VI proportionately increases β-adrenergic receptor-stimulated production of cAMP in neonatal rat cardiac myocytes. Proc. Natl. Acad. Sci. USA. 95:1998;1038-1043.
9. Gao Y.S., Tolsa J.F., Botello M., Raj J.U. Developmental change in isoproterenol-mediated relaxation of pulmonary veins of fetal and newborn lambs. J. Appl. Physiol. 84:1998;1535-1539.
10. Goldstein L.B., Bullman S. Effects of dorsal noradrenergic bundle lesions on recovery after sensorimotor cortex injury. Pharmacol. Biochem. Behav. 58:1997;1151-1157.
11. Heinsimer J.A., Lefkowitz R.J. The impact of aging on adrenergic receptor function: clinical and biochemical aspects. J. Am. Geriatr. Soc. 33:1985;184-188.
12. Hurley J.H. Structure, mechanism, and regulation of mammalian adenylyl cyclase. J. Biol. Chem. 274:1999;7599-7602.
13. Kaneko S., Maeda T., Kume T., Kochiyama H., Akaike A., Shimohama S., Kimura J. Nicotine protects cultured cortical neurons against glutamate-induced cytotoxicity via α7-neuronal receptors and neuronal CNS receptors. Brain Res. 765:1997;135-140.
14. Langston J.W. Methylenedioxymethamphetamine selectively damage central serotonergic neurons in nonhuman primates. J. Am. Med. Assoc. 260:1988;51-55.
15. Makman M.H., Ahn H.S., Thal L.J., Sharpless N.S., Dvorkin B., Horowitz S.G., Rosenfeld M. Evidence for selective loss of brain dopamine- and histamine-stimulated adenylate cyclase activities in rabbits with aging. Brain Res. 192:1980;177-183.
16. Meister B., Johnson H., Ulfhake B. Increased expression of serotonin transporter messenger RNA in raphe neurons of the aged rat. Mol. Brain Res. 33:1995;87-96.
17. Miller D.B., O'Callaghan J.P. The role of temperature, stress, and other factors in the neurotoxicity of the substituted amphetamines 3,4-methylenedioxymethamphetamine and fenfluramine. Mol. Neurobiol. 11:1995;177-192.
18. 3H-paroxetine binding to the serotonin transporter is insensitive to changes in central serotonergic innervation in the rat. Psychiat. Res. 38:1991;97-104.
19. Muscari C., Caldarera I., Rapezzi C., Branzi A., Caldarera C.M. Biochemical correlates with myocardial aging. Cardioscience. 3:1992;67-78.
20. Narayanan N., Derby J.A. Alterations in the properties of β-adrenergic receptors of myocardial membranes in aging: impairments in agonist-receptor interactions and guanine nucleotide regulation accompany diminished catecholamine-responsiveness of adenylate cyclase. Mech. Ageing Dev. 19:1982;127-139.
21. Narayanan N., Tucker L. Autonomic interactions in the aging heart: age-associated decrease in muscarinic cholinergic receptor mediated inhibition of β-adrenergic activation of adenylate cyclase. Mech. Ageing Dev. 34:1986;249-259.
22. Nash J.F., Brokin J. Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dopamine release: effects of dopamine uptake inhibitions. J. Pharmacol. Exp. Ther. 259:1991;820-825.
23. Nelson J.C., Mazure C.M., Jatlow P.I. Desipramine treatment of major depression in patients over 75 years of age. J. Clin. Psychopharmacol. 15:1995;99-105.
24. O'Callaghan J.P., Miller D.B. Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse. J. Pharmacol. Exp. Ther. 270:1994;741-751.
25. Roose S.P., Glassman A.H., Attia E., Woodring S. Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. Am. J. Psychiat. 151:1994;1735-1739.
26. Roth D.M., Gao M.H., Lai N.C., Drumm J., Dalton N., Zhou J.Y., Zhu J., Entrikin D., Hammond K. Cardiac-directed adenylyl cyclase expression improves heart function in murine cardiomyopathy. Circulation. 99:1999;3099-3102.
27. Scarpace P.J., Turner N., Mader S.L. β-Adrenergic function in aging: basic mechanisms and clinical implications. Drugs Aging. 1:1991;116-129.
28. Shankaran M., Yamamoto B.K., Gudelsky G.A. Mazindol attenuates the 3,4-methylenedioxymethamphetamine-induced formation of hydroxy radicals and long term depletion of serotonin in the striatum. J. Neurochem. 72:1999;2516-2522.
29. Shu Y., Scarpace P.J. Forskolin binding sites and G-protein immunoreactivity in rat hearts during aging. J. Cardiovasc. Pharmacol. 23:1994;188-193.
30. Sirvio J., Riekkinen P., Valjakka A., Jolkkonen J., Riekkinen P.J. The effects of noradrenergic neurotoxin, DSP-4, on the performance of young and aged rats in spatial navigation task. Brain Res. 563:1991;297-302.
31. Slotkin T.A., Hays J.C., Nemeroff C.B., Carroll B.J. Dexamethasone Suppression Test identifies a subset of elderly depressed patients with reduced platelet serotonin transport and resistance to imipramine inhibition of transport. Depression Anxiety. 6:1997;19-25.
32. Slotkin T.A., McCook E.C., Ritchie J.C., Carroll B.J., Seidler F.J. Serotonin transporter expression in rat brain regions and blood platelets: aging and glucocorticoid effects. Biol. Psychiat. 41:1997;172-183.
33. Slotkin T.A., Miller D.B., Fumagalli F., McCook E.C., Zhang J., Bissette G., Seidler F.J. Modeling geriatric depression in animals: biochemical and behavioral effects of olfactory bulbectomy in young versus aged rats. J. Pharmacol. Exp. Ther. 289:1999;334-345.
34. Slotkin T.A., Seidler F.J., Ritchie J.C. Effects of aging and glucocorticoid treatment on monoamine oxidase subtypes in rat cerebral cortex: therapeutic implications. Brain Res. Bull. 47:1998;345-348.
35. Slotkin T.A., Thai L., McCook E.C., Saleh J.L., Zhang J., Seidler F.J. Aging and glucocorticoids: effects on cell signaling mediated through adenylyl cyclase. J. Pharmacol. Exp. Ther. 279:1996;478-491.
36. Slotkin T.A., Zhang J., McCook E.C., Seidler F.J. Glucocorticoid-targeting of the adenylyl cyclase signaling pathway in the cerebellum of young vs. aged rats. Brain Res. 800:1998;236-244.
37. Snedecor G.W., Cochran W.G. Statistical Methods. 1967;Iowa State University Press, Ames, Iowa.
38. Urasawa K., Murakami T., Yasuda H. Age-related alterations in adenylyl cyclase system of rat hearts. Japan. Circ. J. 55:1991;676-684.
39. White M., Roden R., Minobe W., Khan M.F., Larrabee P., Wollmering M., Port J.D., Anderson F., Campbell D., Feldman A.M., Bristow M.R. Age-related changes in β-adrenergic neuroeffector systems in the human heart. Circulation. 90:1994;1225-1238.
40. Yamashita H., Nakamura S. Nicotine rescues PC12 cells from death induced by nerve growth factor deprivation. Neurosci. Lett. 213:1996;145-147.
41. Zeiders J.L., Seidler F.J., Slotkin T.A. Ontogeny of regulatory mechanisms for β-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit. J. Mol. Cell. Cardiol. 29:1997;603-615.
42. Zeiders J.L., Seidler F.J., Slotkin T.A. Agonist-induced sensitization of β-adrenoceptor signaling in neonatal rat heart: expression and catalytic activity of adenylyl cyclase. J. Pharmacol. Exp. Ther. 291:1999;503-510.